Stock Movers

On this episode of Stock Movers: - Newsmax (NMAX) shares jump, putting the conservative media outlet’s stock on track to extend gains after it jumped 735% in its debut on Monday. Newsmax Inc.’s debut as a public company has given founder and Chief Executive Officer Christopher Ruddy a fortune of about $3.3 billion.The conservative cable news network sold $75 million of shares at $10 each in Monday’s initial public offering.- Live Nation (LYV) shares took a hit after President Donald Trump signed an executive order cracking down on ticket scalping and fees that drive up the costs of attending live events for consumers. The order directs the Federal Trade Commission to work with the Department of Justice to ensure that competition laws are enforced in the concert and entertainment industry — including the Better Online Ticket Sales, or BOTS, Act.- PVH Corp., the owner of the Calvin Klein and Tommy Hilfiger brands, is expecting sales growth to be flat or slightly positive this year, outpacing analysts’ expectations.The outlook, which excludes currency fluctuations, surpasses the average analyst estimate of a 0.5% revenue decline for the period from the previous year.See omnystudio.com/listener for privacy information.

On this episode of Stock Movers:- Shake Shack (SHAK) shares rose after Loop Capital Markets upgraded the burger chain’s stock to buy from hold, citing a recent pullback in shares as well as potential upside to the company’s earnings.- Johnson & Johnson (JNJ) shares fall after a federal judge rejected the health-care products maker’s third attempt to use the bankruptcy of one of its small units to end baby powder cancer claims. Analysts said this added to the overhang on the shares given the uncertainty over how the company will deal with the claims.- Newsmax (NMAX) shares jump, putting the conservative media outlet’s stock on track to extend gains after it jumped 735% in its debut on Monday. Newsmax Inc.’s debut as a public company has given founder and Chief Executive Officer Christopher Ruddy a fortune of about $3.3 billion.The conservative cable news network sold $75 million of shares at $10 each in Monday’s initial public offering.See omnystudio.com/listener for privacy information.

On this episode of Stock Movers:- Newsmax (NMAX) shares popped after opening 40% above their initial public offering price of $10 apiece, before triggering a halt for volatility. The cable news network raised $75 million from the sale of 7.5 million shares, according to a statement Mar. 28, and its IPO has given founder and CEO Christopher Ruddy a fortune of about $3.3 billion after its shares surged 735%.- Johnson & Johnson (JNJ) is falling after a federal judge rejected the health-care products maker’s third attempt to use bankruptcy of one of its small units to end baby powder cancer claims. Analysts said that this added to the overhang on the shares given the uncertainty over how it will deal with the claims.- Live Nation (LYV) shares are down after President Trump signed an executive order cracking down on ticket scalping and fees that drive up the costs of attending live events for consumers. The order directs the Federal Trade Commission and other agencies to ensure competition laws are enforced, promote price transparency, and prevent ticket resellers from gouging consumers.- Microvast Holdings (MVST) jumped as much as 56% in US premarket trading after the lithium-ion battery maker reported 2024 revenue that beat its guidance thanks to growing demand for its technology.See omnystudio.com/listener for privacy information.

On this episode of Stock Movers:- Newsmax (NMAX) shares popped after opening 40% above their initial public offering price of $10 apiece, before triggering a halt for volatility. The cable news network raised $75 million from the sale of 7.5 million shares, according to a statement Mar. 28, and its IPO has given founder and CEO Christopher Ruddy a fortune of about $3.3 billion after its shares surged 735%.- Johnson & Johnson (JNJ) is falling after a federal judge rejected the health-care products maker’s third attempt to use bankruptcy of one of its small units to end baby powder cancer claims. Analysts said that this added to the overhang on the shares given the uncertainty over how it will deal with the claims.- Tesla (TSLA) shares are up premarket after the stock closed with a loss Monday and ended the first quarter down 36%. It comes as other Magnificent 7 stocks decline and after reports of more negative sales news out of Europe: Tesla car sales in France plunged 37% in March.- Live Nation (LYV) shares are down after President Trump signed an executive order cracking down on ticket scalping.See omnystudio.com/listener for privacy information.

On this episode of Stock Movers:- AstraZeneca's experimental cholesterol drug significantly reduced “bad” cholesterol in a mid-stage trial, boosting hopes for a potential blockbuster that could be part of a powerful combination medicine targeting weight loss and related ailments. The once-a-day pill led to a 50.7% reduction in low-density lipoprotein cholesterol, often called LDL, when given on top of statins, according to data presented at the American College of Cardiology in Chicago.- UK supermarket stocks decline as analysts cut profit estimates following a recent profit warning from Asda who are reducing prices on 10,000 items, likely signaling a period of more aggressive market activity after managing challenges from Aldi and Lidl. Tesco and Sainsbury's will have to respond to Asda, which is seeking to reestablish itself as the UK's cheapest full-line supermarket.- Travis Perkins shares fall as much as 13% to their lowest since June 2009 after the wholesaler said there was uncertainty regarding recovery in UK construction activity and challenging market conditions have continued. Citi sees consensus downgrades on the back of the guidance.See omnystudio.com/listener for privacy information.

On this episode of Stock Movers:- Canada Goose (GOOS) shares fell today on the news that Barclays was cutting the upscale parka retailer's rating to "underweight" from "equal weight", citing challenging macro pressures. - Vaccine and biotech stocks, including Moderna (MRNA) plunged after a top regulator left the US Food and Drug Administration, casting deep uncertainty about the future of vaccines and cutting-edge gene therapies. Peter Marks, a key figure overseeing the review and approval of vaccines and other medications, resigned on Friday, citing friction with the views of new Health and Human Services Secretary and longtime vaccine critic Robert F. Kennedy Jr. - Celsius Holdings (CELH) shares rose to hit its highest intraday level since September after Truist Securities upgraded its recommendation to buy from hold, saying the company’s Alani Nu acquisition gives it an “extremely strong position” in the women’s segment of the US energy drink category.See omnystudio.com/listener for privacy information.

On this episode of Stock Movers:- Vaccine and biotech stocks, including Moderna (MRNA) plunged after a top regulator left the US Food and Drug Administration, casting deep uncertainty about the future of vaccines and cutting-edge gene therapies. Peter Marks, a key figure overseeing the review and approval of vaccines and other medications, resigned on Friday, citing friction with the views of new Health and Human Services Secretary and longtime vaccine critic Robert F. Kennedy Jr. - Celsius Holdings (CELH) shares rose to hit its highest intraday level since September after Truist Securities upgraded its recommendation to buy from hold, saying the company’s Alani Nu acquisition gives it an “extremely strong position” in the women’s segment of the US energy drink category. - Newsmax (NMAX) shares skyrocketed as much as 683% in their debut session, as individual investors piled into the conservative media outlet after its initial public offering. Shares were repeatedly halted for volatility. Newsmax raised $75 million in the offering, selling 7.5 million shares for $10 apiece. The mania for a loss-making cable news network stands in dramatic contrast with the year’s biggest and most high-profile IPOs, after Venture Global and CoreWeave realized valuations far less than initially proposed and have traded down in the days after their debuts.See omnystudio.com/listener for privacy information.

On this episode of Stock Movers:- Makers of vaccines and gene therapies, among other biotech companies, are seeing their shares tumble in Monday trading after the FDA’s top regulator for such therapies, Peter Marks, abruptly resigned. Vaccine stocks fall: Moderna -12%, Novavax -7%, BioNTech-8.0%, CureVac -7.2%, Vir Biotechnology -4.2%, Pfizer -1.6%- Tesla is leading losses among the Magnificent Seven stocks on Monday ahead of President Donald Trump’s deadline for a new set of sweeping global trade tariffs.-Canada Goose shares fall 4.7% in premarket trading on Monday as Barclays cuts the upscale parka retailer’s rating to underweight from equal-weight, citing challenging macro pressuresSee omnystudio.com/listener for privacy information.

On this episode of Stock Movers:- Tesla (TSLA) shares are down amid President Trump's incoming auto tariffs and as it expects to released its first-quarter deliveries on Wednesday. The electric car company snapped its nine-week losing streak last week, though it is down 35% on the year entering the trading day.- Nvidia (NVDA) dropped pre-market following a disappointing IPO from the company it's backing, CoreWeave. The pure play AI start-up began trading Friday and shares fell below its offering price of $40. Nvidia's down 18% on the year coming into Monday.- Newmont Corp. (NEM) shares are rising as gold prices rise and investors make defensive plays amid policy uncertainty about US tariffs. - Moderna (MRNA) shares declined in premarket trading following the fiery resignation of Dr. Peter Marks, who led the FDA's Center for Biologics Evaluation and Research. Marks' quick approval for medicines for rare diseases has helped biotech companies, and the sector has sold off on the news.See omnystudio.com/listener for privacy information.

On this episode of Stock Movers:- Newmont Corp. (NEM) shares are rising as gold prices rise and investors make defensive plays amid policy uncertainty about US tariffs. - Palantir (PLTR) shares are sliding in the premarket as investors exposed to the AI trade continues to weigh on Magnificent 7 stocks.- Nvidia (NVDA) dropped pre-market following a disappointing IPO from the company it's backing, CoreWeave. The pure play AI start-up began trading Friday and shares fell below its offering price of $40. Nvidia's down 18% on the year coming into Monday.- Tesla (TSLA) shares are down amid President Trump's incoming auto tariffs and as it expects to released its first-quarter deliveries on Wednesday. The electric car company snapped its nine-week losing streak last week, though it is down 35% on the year entering the trading day.See omnystudio.com/listener for privacy information.